Open tender · Germany · Cn Standard
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Natalizumab (ATC-Code: L04AG03).
AOK Niedersachsen. Die Gesundheitskasse.
The work
Conclusion of a non-exclusive discount contract for the active substance Natalizumab (ATC-Code: L04AG03) in an 'open-house-model'.
- Contract duration is a maximum of 24 months.
- Earliest contract start is 01.10.2025.
- All contracts end no later than 30.09.2027.
Key facts
- Contract period
- Maximum 24 months, ending no later than 30.09.2027.
- Evaluation
- This is not a public procurement in the sense of Directive 2014/24/EU, so a formal evaluation method is not specified.
What it takes to qualify
Worth a closer look
- The text states this is not a public procurement, which may imply a different set of compliance requirements not detailed here.
- The requirement for a 'Vorlauf von in der Regel 35 Kalendertagen' is a procedural note but could be a hard gate for submission timing.
Experience
- At least 1 similar work — Prior experience with pharmaceutical discount contracts is implied by the requirement to be a 'pharmazeutischer Unternehmer'.
- Experience with non-exclusive discount contracts for pharmaceuticals.
Certifications and registrations
Pharmazeutischer Unternehmer statusMust be a pharmaceutical entrepreneur as defined by § 4 Abs. 18 AMG.
GST registration (optional)Not mentioned in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- VertragsunterlagenContract documents must be submitted to the AOK Niedersachsen.